792 FULL EVALUATION OF LEFT ATRIAL FUNCTION AFTER MITRACLIP IMPLANTATION


 
 
 interventional edge-to-edge repair by MitraClip ™ is widely demonstrated to be able to reduce the degree of MR in patients with high surgical risk. The left atrial (LA) dysfunction in patients with severe MR is associated with poor prognosis and its changes after MV repair is reported in several studies. While, little is known about the full evaluation of the LA function by Two-dimensional speckle echocardiography tracking (2D STE)
 
 
 
 from March 2015 to December 2021, clinical and echocardiographic data of 67 patients with MR who underwent Mitraclip™ implantation in our division were evaluated for LA function. Strain Reservoir (S_R), Conduit Strain (S_Cd), Contractile Strain (S_Ct), LA emptying Fraction (LAEF_4CH), LAESV (Left atrial end-systolic volume), LAEDV (Left atrial end-diastolic volume) at baseline, at 1 month, at 6 months and 1 year of follow up were assessed. The variation of continuous variables was evaluated using a student T test for paired data. The categorical variables between baseline, at 1 month, at 6 months and 1 year of follow up were evaluated using the ANOVA test. The Multiple Bonferroni test comparison was conducted as a post hoc analysis P values <0.05 were considered significant.
 
 
 
 the etiology of the MR was primary in 29,2% and secondary in 70,8% of the included patients. The MR degree was 3+ in 16,9% of patients and 4+ in 81,5%. When compared to baseline at 6 months and 1 year a statistically significant improvement was observed for LAEF_4CH (p 0.006 and <0.001) and at 1 year for S_R (p 0.013) and S_Cd (p 0.033). When compared at 1 month the S-R improvement was observed at 6 months and 1 year (shown in Table 1). Finally, no significant changes were observed in S_Ct at different time point analyzed.
 
 
 
 the MR improvement after MitraClip™ procedure allows hemodynamic changes with LA remodeling which can be detected by 2D STE through an improvement in LA function. These data emphasize the hypothesis that these echocardiographic parameters represent an advanced method to evaluate the response to device implantation.
